Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Loop-mediated isothermal amplification: rapid visual and real-time methods for detection of genetically modified crops.

Randhawa GJ, Singh M, Morisset D, Sood P, Zel J.

J Agric Food Chem. 2013 Nov 27;61(47):11338-46. doi: 10.1021/jf4030085. Epub 2013 Nov 15.

PMID:
24188249
2.

HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.

Masutani K, Ninomiya T, Randhawa P.

Nephrol Dial Transplant. 2013 Dec;28(12):3119-26. doi: 10.1093/ndt/gft298. Epub 2013 Sep 30.

3.

"Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort.

Castillo-Rama M, Sebagh M, Sasatomi E, Randhawa P, Isse K, Salgarkar AD, Ruppert K, Humar A, Demetris AJ.

Am J Transplant. 2013 Nov;13(11):2966-77. doi: 10.1111/ajt.12413. Epub 2013 Sep 6.

4.

Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.

Momper JD, Zhao Y, Shapiro R, Schonder KS, Gao Y, Randhawa PS, Venkataramanan R.

Transpl Infect Dis. 2013 Feb;15(1):34-41. doi: 10.1111/tid.12014. Epub 2012 Oct 2.

5.

Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia.

Masutani K, Shapiro R, Basu A, Tan H, Ninomiya T, Randhawa P.

Transplantation. 2012 Jul 15;94(1):43-9. doi: 10.1097/TP.0b013e318253e7a4.

6.

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.

Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB.

PLoS Pathog. 2012;8(4):e1002650. doi: 10.1371/journal.ppat.1002650. Epub 2012 Apr 12.

7.

The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.

Masutani K, Shapiro R, Basu A, Tan H, Wijkstrom M, Randhawa P.

Am J Transplant. 2012 Apr;12(4):907-18. doi: 10.1111/j.1600-6143.2012.03993.x. Epub 2012 Mar 5.

8.

Inhibitory interactions between BK and JC virus among kidney transplant recipients.

Cheng XS, Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Randhawa P, Hardinger KL, Brennan DC.

J Am Soc Nephrol. 2011 May;22(5):825-31. doi: 10.1681/ASN.2010080877. Epub 2011 Apr 21.

9.

The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy.

Batal I, Zainah H, Stockhausen S, Basu A, Tan H, Shapiro R, Zeevi A, Girnita A, Randhawa P.

Mod Pathol. 2009 Nov;22(11):1468-76. doi: 10.1038/modpathol.2009.118. Epub 2009 Sep 4.

10.

Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction.

Batal I, Franco ZM, Shapiro R, Basu A, Tan H, Kayler L, Zeevi A, Morgan C, Randhawa P.

Hum Pathol. 2009 Sep;40(9):1312-9. doi: 10.1016/j.humpath.2009.01.018. Epub 2009 Apr 22.

PMID:
19386348
11.

Antirejection treatment in kidney transplant patients with BK viruria.

Kayler LK, Batal I, Mohanka R, Morgan C, Basu A, Shapiro R, Randhawa PS.

Transplantation. 2008 Sep 27;86(6):797-803. doi: 10.1097/TP.0b013e3181837802.

12.

longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.

Randhawa P, Bohl D, Brennan D, Ruppert K, Ramaswami B, Storch G, March J, Shapiro R, Viscidi R.

Clin Vaccine Immunol. 2008 Oct;15(10):1564-71. doi: 10.1128/CVI.00206-08. Epub 2008 Aug 27.

13.

Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation.

Batal I, Zeevi A, Heider A, Girnita A, Basu A, Tan H, Shapiro R, Randhawa P.

Am J Clin Pathol. 2008 Apr;129(4):587-91. doi: 10.1309/23YGPB1E758ECCFP.

14.

Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Randhawa PS, Gupta G, Vats A, Shapiro R, Viscidi RP.

Clin Vaccine Immunol. 2006 Sep;13(9):1057-63.

15.

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.

Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, Wu C, Donaldson J, Dvorchik I, Kayler L, Marcos A, Randhawa P, Smetanka C, Starzl TE, Shapiro R.

Am J Transplant. 2006 Oct;6(10):2409-17. Epub 2006 Aug 4.

16.

Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro.

Randhawa P, Farasati NA, Shapiro R, Hostetler KY.

Antimicrob Agents Chemother. 2006 Apr;50(4):1564-6.

17.

Anti-BK virus activity of ciprofloxacin and related antibiotics.

Randhawa PS.

Clin Infect Dis. 2005 Nov 1;41(9):1366-7; author reply 1367. No abstract available.

18.

A comparative study of BK and JC virus infections in organ transplant recipients.

Randhawa P, Uhrmacher J, Pasculle W, Vats A, Shapiro R, Eghtsead B, Weck K.

J Med Virol. 2005 Oct;77(2):238-43.

PMID:
16121361
19.

Quantitation of DNA of polyomaviruses BK and JC in human kidneys.

Randhawa P, Shapiro R, Vats A.

J Infect Dis. 2005 Aug 1;192(3):504-9. Epub 2005 Jun 22.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk